At the time of writing, Biohaven Ltd [BHVN] stock is trading at $13.51, down -1.82%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The BHVN shares have gain 13.34% over the last week, with a monthly amount glided 22.82%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biohaven Ltd [NYSE: BHVN] stock has seen the most recent analyst activity on January 21, 2026, when RBC Capital Mkts upgraded its rating to a Outperform but kept the price target unchanged to $22 for it. Previously, H.C. Wainwright downgraded its rating to Neutral on December 03, 2025, and kept the price target unchanged to $11. On November 26, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $11 on the stock. Bernstein downgraded its rating to a Mkt Perform but stick to its price target of $9 on November 06, 2025. BofA Securities downgraded its rating to a Neutral but $10 remained the price target by the analyst firm on November 05, 2025. Citigroup started tracking with a Buy rating for this stock on September 17, 2025, and assigned it a price target of $28. In a note dated September 03, 2025, Raymond James initiated an Strong Buy rating and provided a target price of $75 on this stock.
For the past year, the stock price of Biohaven Ltd fluctuated between $7.48 and $44.28. Currently, Wall Street analysts expect the stock to reach $22.4 within the next 12 months. Biohaven Ltd [NYSE: BHVN] shares were valued at $13.51 at the most recent close of the market. An investor can expect a potential return of 65.8% based on the average BHVN price forecast.
Analyzing the BHVN fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.91, Equity is -3.9 and Total Capital is -2.68. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -18.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Biohaven Ltd [NYSE:BHVN] has a current ratio of 2.86. Also, the Quick Ratio is 2.86, while the Cash Ratio stands at 1.64.
Transactions by insiders
Recent insider trading involved Clark George C., VP, Chief Accounting Officer, that happened on Nov 17 ’25 when 17000.0 shares were purchased. Director, Bailey Gregory completed a deal on Nov 13 ’25 to buy 0.4 million shares. Meanwhile, Director CHILDS JOHN W bought 3.33 million shares on Nov 13 ’25.
